Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) showed up in the 13F filings of 63 institutional investors as of December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| Samsara BioCapital, LLC | 31 Mar, 2026 | 8,500,000 | 0 | 0.00% | $6,245,800.00 |
| RA CAPITAL MANAGEMENT, L.P. | 31 Mar, 2026 | 8,500,000 | 0 | 0.00% | $6,245,800.00 |
| RA CAPITAL MANAGEMENT, L.P. | 31 Mar, 2026 | 8,500,000 | 8,500,000 | 0.00% | $11,475,000.00 |
| Samsara BioCapital, LLC | 31 Mar, 2026 | 8,500,000 | 8,500,000 | 0.00% | $11,475,000.00 |
| AWM Investment Company, Inc. | 31 Mar, 2026 | 6,500,000 | 6,500,000 | 0.00% | $8,775,000.00 |
| AWM Investment Company, Inc. | 31 Mar, 2026 | 6,500,000 | 0 | 0.00% | $4,776,200.00 |
| SymBiosis Capital Partners, LLC | 31 Mar, 2026 | 6,300,000 | 6,300,000 | 0.00% | $8,505,000.00 |
| VANGUARD GROUP INC | 31 Mar, 2026 | 5,109,368 | 4,224,759 | 477.58% | $6,897,647.00 |
| VANGUARD CAPITAL MANAGEMENT LLC | 31 Mar, 2026 | 4,622,567 | 4,622,567 | 0.00% | $3,397,587.00 |
| SymBiosis Capital Partners, LLC | 31 Mar, 2026 | 3,667,585 | -2,632,415 | -41.78% | $2,694,941.00 |
| Longaeva Partners L.P. | 31 Mar, 2026 | 2,329,459 | 216,024 | 10.22% | $1,711,686.00 |
| Longaeva Partners L.P. | 31 Mar, 2026 | 2,113,435 | 2,113,435 | 0.00% | $2,853,137.00 |
| Siren, L.L.C. | 31 Mar, 2026 | 2,000,000 | 0 | 0.00% | $1,469,600.00 |
| Siren, L.L.C. | 31 Mar, 2026 | 2,000,000 | 2,000,000 | 0.00% | $2,700,000.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Mar, 2026 | 903,298 | 42,357 | 4.92% | $664,060.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Mar, 2026 | 860,941 | 564,031 | 189.97% | $1,162,636.00 |
| Goldman Sachs Group Inc | 31 Mar, 2026 | 571,664 | 571,664 | 0.00% | $771,746.00 |
| BlackRock, Inc. | 31 Mar, 2026 | 556,889 | 29,177 | 5.53% | $409,202.00 |
| BlackRock, Inc. | 31 Mar, 2026 | 527,712 | 407,480 | 338.91% | $712,412.00 |
| Nan Fung Group Holdings Ltd | 31 Mar, 2026 | 493,584 | 0 | 0.00% | $362,686.00 |